After participating in this educational activity, attendees should be able to:
1. Review the new recommendations on how to describe the findings of HRT
2. Describe the differences between current and prior guidelines
3. Point our key differences between categories of interstitial lung disease


William Moore, MD
NYU Langone Health
NYU Langone Health

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

Dr. Moore is a consultant for BTG Owner Right Dose Inc., a Consultant Merck and Dohme, and Consultant Pfizer Medical

None of the members of the planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.                    

Session date: 
12/15/2021 - 8:00am to 9:00am EST
Webinar Live
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.